Cano Health Inc Ordinary Shares - Class A Stock (OTC: CANOQ)

Cano Health Inc Ordinary Shares - Class A (OTC:CANOQ) Stock, Quote.Headers.trade-ideas

Cano Health Inc Ordinary Shares - Class A

WIIM

SNGX

Soligenix shares are trading higher after the company announced interim data from its investigator-initiated study of HyBryte for early-stage cutaneous T-cell lymphoma, which showed over 70% of patients who completed at least 18 weeks of therapy achieved "Treatment Success."

HC Wainwright &amp; Co. analyst Ed Arce reiterates NewAmsterdam Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) with a Buy and maintains $48 price target.

News

Price Target

Reiteration

Analyst Ratings

NAMS

HC Wainwright & Co. Reiterates Buy on NewAmsterdam Pharma, Maintains $48 Price Target

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4339256-1&amp;h=3514986950&amp;u=https%3A%2F%2Fatlassalt.com%2F&amp;a=Atlas+Salt%2C+Inc.">Atlas Salt, Inc.</a>, a new developer in Canada's mining industry, is digging into Oracle's project and financial management solutions to support the development of the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4339256-1&amp;h=605356699&amp;u=https%3A%2F%2Fatlassalt.com%2Fdeposit%2F&amp;a=Great+Atlantic+Salt+(GAS)+deposit">Great Atlantic Salt (GAS) deposit</a>. The GAS project, which is set to initially produce up to 2.5 million tons of rock salt annually, represents North America's first new salt mine in nearly three decades.
 &nbsp;

ORCL

Atlas Salt Partners with Oracle to Advance Development of North America's First New Salt Mine in 30 Years

Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the advancement of research to assess a patient's brain age - an estimation of the biological age of a person's brain – via its FDA-cleared BNA&#x2122; technology platform.

Government

Regulations

AIFF

Firefly Neuroscience Advances AI-Driven Brain Age Assessment with FDA-Cleared BNA Technology

JP Morgan analyst Arun Jayaram maintains Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) with a Overweight and raises the price target from $36 to $38.

JP Morgan Maintains Overweight on Antero Resources, Raises Price Target to $38

Calumet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) (the "Company," "Calumet," "we," "our" or "us") announced today preliminary selected financial results for the fourth quarter ended December 31, 2024.
Based on preliminary data, the Company currently expects to report a net loss between $54 million and $24 million and Adjusted EBITDA between $45 million and $60 million for the fourth quarter 2024.&nbsp; For a reconciliation of the preliminary estimate of Adjusted EBITDA to preliminary estimated net loss, the most directly comparable GAAP measure, see "Non-GAAP Financial Measures" below.&nbsp;
Finally, we expect capital expenditures in 2025 of $50 million to $70 million in our specialties business and $10 million to $20 million of maintenance capital at Montana Renewables before our MaxSAF project.&nbsp; MaxSAF spending is expected to be $40 million to $60 million in 2025, of which 45%, or $18 million to $27 million, is expected to be funded from MRL operating cash flow, and the remainder from the next tranche of the DOE loan.&nbsp;
 &nbsp;

Guidance

CLMT

Calumet Expects Q4 Net Loss Of $54M-$24M, Adj EBITDA Of $45M-$60M

HC Wainwright &amp; Co. analyst Ed Arce maintains Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) with a Buy and raises the price target from $390 to $400.

MDGL

HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $400

JP Morgan analyst Mark Strouse maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Overweight and raises the price target from $367 to $374.

JP Morgan Maintains Overweight on GE Vernova, Raises Price Target to $374

Truist Securities analyst Barry Jonas maintains Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) with a Buy and lowers the price target from $52 to $48.

Truist Securities Maintains Buy on Caesars Entertainment, Lowers Price Target to $48

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Buy and maintains $57 price target.

APLS

HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $57 Price Target

Truist Securities analyst Barry Jonas maintains Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) with a Hold and lowers the price target from $56 to $49.

Truist Securities Maintains Hold on Red Rock Resorts, Lowers Price Target to $49

Truist Securities analyst Barry Jonas maintains Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) with a Buy and raises the price target from $77 to $85.

Truist Securities Maintains Buy on Boyd Gaming, Raises Price Target to $85

Benchmark analyst David Williams reiterates D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and maintains $8 price target.

QBTS

Benchmark Reiterates Buy on D-Wave Quantum, Maintains $8 Price Target

DA Davidson analyst Michael Baker downgrades RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) from Buy to Neutral and announces $5 price target.

Downgrades

RMBL

DA Davidson Downgrades RumbleON to Neutral, Announces $5 Price Target

Sinclair, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>), the "Company" or "Sinclair," today announced that Sinclair Television Group, Inc. ("STG") and certain affiliated entities have entered into a Transaction Support Agreement (including the attached term sheet and other attachments thereto, the "TSA") with certain of STG's secured creditors (the "Consenting Creditors"), including lenders holding term loans (the "Existing Term Loan Facility") under STG's existing credit facilities (the "Existing Credit Facilities") governed by STG's existing bank credit agreement (the "Existing Credit Agreement") and various holders of STG's outstanding 4.125% Senior Secured Notes due 2030 (the "Existing Secured Notes"), on the principal terms of new money financings and a debt recapitalization (the "Transactions") to strengthen the Company's balance sheet and better position it for long-term growth.

SBGI

Sinclair Announces Debt Recapitalization Agreement with Creditors to Strengthen Financial Position

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) with a Buy and maintains $38 price target.

NVCR

HC Wainwright & Co. Reiterates Buy on NovoCure, Maintains $38 Price Target

John Armstrong, Executive Vice President of LPCcommented:
"With a strong foundation laid in 2024, we're entering 2025 with clear momentum and an unwavering focus on growth. The progress we made last year - strengthening our position in core markets and breaking into high-potential segments, sets the stage for what we believe will be transformative advancements. From leveraging synergies with our CMS acquisition to scaling our cutting-edge products like CleanTech, we're poised to redefine what's possible in industrial laser technology. As we look ahead, LPC is committed to delivering value through relentless innovation, improved operational excellence and strategic expansion – we are determined to lead the way in industrial laser solutions."

LASE

Laser Photonics Outlines 2025 Growth Path: Strengthening Core Technologies And Expanding Market Reach

Mawson Infrastructure Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) ("Mawson" or "the Company"), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets markets, today announced its unaudited business and operational update for December 2024.
<ul>
<li>Digital Colocation Monthly Business Revenue was up 69% Y/Y, to about $4.49 million growing from $2.66 million in December 2023, and up 8% M/M growing from $4.18 million in November 2024.</li>
<li>Total Monthly Revenue up 7% M/M to about $5.26 million from $4.9 million in November 2024.</li>
<li>Monthly Energy Management Business Revenue was up 25% M/M from $0.33 million in November 2024 to $0.41 million in December 2024 and Digital Assets Mining Monthly Business Revenue was $0.36 million.</li>
<li>Total Current Operating Hash Rate (EH) is about 4.98 EH/s (exahashes per second)</li>
<li>Mawson recently signed a new digital colocation customer agreement with a NASDAQ-listed publicly traded company as a customer on January 3, 2025
<ul>
<li>Digital colocation services for 5,880 miners or approximately 20 MW at Mawson's facilities, initial digital colocation customer agreement term is for 12 months, and the parties can extend upon mutual agreement.</li>
<li>Further strengthens Mawson's position as a leading industry provider of digital infrastructure and colocation services in the attractive PJM market, which is North America's largest competitive and deregulated wholesale power market.</li>
<li>Upon completion of this deployment, Mawson expects to operate and manage approximately 41,500 miners.</li>
<li>Combined Total Current Operating Hash Rate (EH) expected to increase to about 5.10 EH/s (includes colocation and self-mining across our facilities).1</li>
</ul>
</li>
<li>Company also has an additional site in Ohio under development which is expected to add an initial 24 MW to the Company's currently operating 129 MW across its sites, growing the Company's total operating capacity to 153 MW, upon completion with further potential expansion of its hashrate.</li>
<li>Mawson supports innovative, agile, efficient, and scalable approaches to AI infrastructure and compute, and invites AI/HPC ecosystem companies to discuss opportunities to collaborate on artificial intelligence, high-performance and accelerated computing solutions.</li>
</ul>

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Reports 69% Growth in Colocation Revenue, Secures New Colocation Deal, Projects Hash Rate Increase with Expanded Ohio Facility

CICC analyst Zijie Yang initiates coverage on Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Outperform rating.

Initiation

RBLX

CICC Initiates Coverage On Roblox with Outperform Rating

QUIK

QuickLogic Expands Into Turkiye And UAE With Magenta Distribution Agreement

Cano Health (CANOQ) has issued an announcement. Cano Health Inc. and its affiliates, under Chapter 11 bankruptcy proceedings, have proposed a Joint...

Cano Health Proposes Reorganization Plan Amid Bankruptcy

Spreads In Control

The latest announcement is out from Cano Health (CANOQ). Cano Health, Inc. and its subsidiaries, amidst Chapter 11 bankruptcy proceedings, have fil...

Cano Health Unveils Restructuring Strategy Amid Bankruptcy

An announcement from Cano Health (CANOQ) is now available. Cano Health, Inc. and its subsidiaries, collectively known as the Debtors, are in the mi...

Cano Health's Ongoing Chapter 11 Bankruptcy Restructuring

Cano Health expects to emerge from Chapter 11 bankruptcy in Q3

An announcement from Cano Health (CANOQ) is now available. Cano Health, Inc. and its subsidiaries, collectively known as the Debtors, have filed fo...

Cano Health's Chapter 11 Bankruptcy Restructuring Update

Cano Health (CANOQ) has provided an update. Cano Health, Inc. and its subsidiaries have filed for Chapter 11 bankruptcy to restructure their busine...

Cano Health Seeks Bankruptcy for Restructuring and Growth

Cano Health (CANOQ) has shared an announcement. Cano Health, Inc., along with its subsidiaries, is navigating through Chapter 11 bankruptcy proceed...

Comments

Cano Health Inc Ordinary Shares - Class A

Cano Health Inc Ordinary Shares - Class A (CANOQ) Forecast

Cano Health Inc Ordinary Shares - Class A (OTC:CANOQ) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga